Literature DB >> 24477478

Individualized assessments in treatment research: an examination of parent-nominated target problems in the treatment of disruptive behaviors in youth with Tourette syndrome.

Joseph F McGuire1, Denis G Sukhodolsky, Karen Bearss, Heidi Grantz, Maryellen Pachler, Paul J Lombroso, Lawrence Scahill.   

Abstract

Youth with Tourette syndrome (TS) often exhibit disruptive behaviors. Although improvement data on rating scales support the efficacy of structured psychotherapeutic interventions, there is growing interest in personalized outcome assessments. This report examined parent-nominated target problems (PTPs) as an individualized outcome measure in 48 youth with TS and disruptive behaviors, who participated in one of two randomized psychotherapy trials. At baseline, parents described two primary problems to an independent evaluator who generated a structured narrative for each problem. These narratives were reviewed and updated at endpoint. When rated by five treatment-blind judges, the PTP rating demonstrated excellent reliability and good convergent validity with the Disruptive Behavior Rating Scale (DBRS). The PTP rating exhibited comparable treatment effects to the DBRS, and accounted for additional variance in global treatment outcome. The PTP rating serves a reliable, valid, and sensitive personalized assessment in research trials that provides complementary information to standardized rating scales.

Entities:  

Mesh:

Year:  2014        PMID: 24477478     DOI: 10.1007/s10578-014-0437-7

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  24 in total

1.  Randomized trial of parent management training in children with tic disorders and disruptive behavior.

Authors:  Lawrence Scahill; Denis G Sukhodolsky; Karen Bearss; Diane Findley; Vanya Hamrin; Deirdre H Carroll; Adrienne L Rains
Journal:  J Child Neurol       Date:  2006-08       Impact factor: 1.987

2.  A placebo-controlled trial of risperidone in Tourette syndrome.

Authors:  L Scahill; J F Leckman; R T Schultz; L Katsovich; B S Peterson
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

3.  Behavior therapy for children with Tourette disorder: a randomized controlled trial.

Authors:  John Piacentini; Douglas W Woods; Lawrence Scahill; Sabine Wilhelm; Alan L Peterson; Susanna Chang; Golda S Ginsburg; Thilo Deckersbach; James Dziura; Sue Levi-Pearl; John T Walkup
Journal:  JAMA       Date:  2010-05-19       Impact factor: 56.272

4.  Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms.

Authors:  L E Arnold; P H Wender; K McCloskey; S H Snyder
Journal:  Arch Gen Psychiatry       Date:  1972-12

5.  Prevalence and clinical correlates of tic disorders in a community sample of school-age children.

Authors:  Janne Tabori Kraft; Søren Dalsgaard; Carsten Obel; Per Hove Thomsen; Tine Brink Henriksen; Lawrence Scahill
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-27       Impact factor: 4.785

6.  Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.

Authors:  Eric A Storch; Tanya K Murphy; Gary R Geffken; Ohel Soto; Muhammad Sajid; Pam Allen; Jonathan W Roberti; Erin M Killiany; Wayne K Goodman
Journal:  Psychiatry Res       Date:  2004-11-30       Impact factor: 3.222

7.  Clinicians and outcome measurement: what's the use?

Authors:  Ann F Garland; Marc Kruse; Gregory A Aarons
Journal:  J Behav Health Serv Res       Date:  2003 Oct-Dec       Impact factor: 1.505

8.  Prevalence and development of psychiatric disorders in childhood and adolescence.

Authors:  E Jane Costello; Sarah Mustillo; Alaattin Erkanli; Gordon Keeler; Adrian Angold
Journal:  Arch Gen Psychiatry       Date:  2003-08

9.  A measure of functional impairment in youth with Tourette's syndrome.

Authors:  Eric A Storch; Caleb W Lack; Laura E Simons; Wayne K Goodman; Tanya K Murphy; Gary R Geffken
Journal:  J Pediatr Psychol       Date:  2007-05-23

10.  Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

Authors:  L Eugene Arnold; Benedetto Vitiello; Christopher McDougle; Larry Scahill; Bhavik Shah; Nilda M Gonzalez; Shirley Chuang; Mark Davies; Jill Hollway; Michael G Aman; Pegeen Cronin; Kathleen Koenig; Arlene E Kohn; Donald J McMahon; Elaine Tierney
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

View more
  4 in total

1.  Cognitive-Behavioral Therapy for a 9-Year-Old Girl With Disruptive Mood Dysregulation Disorder.

Authors:  Megan E Tudor; Karim Ibrahim; Emilie Bertschinger; Justyna Piasecka; Denis G Sukhodolsky
Journal:  Clin Case Stud       Date:  2016-09-22

2.  Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.

Authors:  Lawrence Scahill; Karen Bearss; Rena Sarhangian; Christopher J McDougle; L Eugene Arnold; Michael G Aman; James T McCracken; Elaine Tierney; Scott Gillespie; Valentina Postorino; Benedetto Vitiello
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-11-28       Impact factor: 2.576

3.  Using caregiver report on the impact of challenging behavior exhibited by children with autism spectrum disorder to guide treatment development and outcomes.

Authors:  Mindy Scheithauer; Colin S Muething; Meghan R Silva; Kristina R Gerencser; Joelle Krantz; Nathan A Call
Journal:  Int J Dev Disabil       Date:  2018-03-07

4.  Using Parent Target Problem Narratives to Evaluate Outcomes in Children with Autism Spectrum Disorder.

Authors:  Elisabeth Sheridan; Scott Gillespie; Cynthia R Johnson; Luc Lecavalier; Tristram Smith; Naomi Swiezy; Kylan Turner; Jill Pritchett; Daniel W Mruzek; Andrea N Evans; Karen Bearss; Lawrence Scahill
Journal:  Res Child Adolesc Psychopathol       Date:  2021-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.